Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)

SHE:300347 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	6,358	6,474	7,289	7,002	5,187	3,176
Other Revenue	137.59	129.04	94.93	83.93	26.17	16.04
Revenue	6,495	6,603	7,384	7,085	5,214	3,192
Revenue Growth (YoY)	-7.63%	-10.58%	4.21%	35.91%	63.32%	13.88%
Cost of Revenue	4,606	4,359	4,539	4,277	2,943	1,678
Gross Profit	1,889	2,244	2,845	2,808	2,271	1,514
Selling, General & Admin	929.65	944.45	837.52	780.02	676.88	487.22
Research & Development	240.7	238.39	261.56	234.62	211.83	156.65
Other Operating Expenses	39.33	22.2	19.15	7.17	12.5	3.67
Operating Expenses	1,232	1,235	1,155	1,046	926.93	635.57
Operating Income	657.45	1,009	1,690	1,763	1,344	878.67
Interest Expense	-128.21	-141.24	-119.9	-83.18	-24.91	-50.78
Interest & Investment Income	356.16	256.86	568.02	330.09	568.16	394.16
Currency Exchange Gain (Loss)	-11.41	18.02	2.61	20.13	-11.83	-147.08
Other Non Operating Income (Expenses)	-11.68	-6.59	-3.32	-6.88	-1.48	-2.48
EBT Excluding Unusual Items	862.31	1,137	2,138	2,023	1,874	1,073
Impairment of Goodwill	-5	-5	-29.16	-	-	-
Gain (Loss) on Sale of Investments	-492.93	-501.69	352.77	535.86	1,815	1,138
Gain (Loss) on Sale of Assets	2.7	3.56	-0.19	-0.09	-0.53	-0.89
Asset Writedown	-	-	-	-0.45	-	-
Other Unusual Items	49.98	31.05	27.24	27.1	-3.96	9.2
Pretax Income	417.06	664.46	2,489	2,585	3,685	2,219
Income Tax Expense	163.98	216.63	338.61	313.65	292.86	189.71
Earnings From Continuing Operations	253.08	447.83	2,150	2,272	3,392	2,029
Minority Interest in Earnings	42.55	-42.69	-125.08	-265.17	-517.54	-279.23
Net Income	295.63	405.14	2,025	2,007	2,874	1,750
Net Income to Common	295.63	405.14	2,025	2,007	2,874	1,750
Net Income Growth	-73.82%	-79.99%	0.91%	-30.19%	64.26%	107.90%
Shares Outstanding (Basic)	857	863	865	865	868	795
Shares Outstanding (Diluted)	857	863	865	866	871	799
Shares Change (YoY)	-1.09%	-0.22%	-0.07%	-0.62%	9.01%	7.27%
EPS (Basic)	0.35	0.47	2.34	2.32	3.31	2.20
EPS (Diluted)	0.35	0.47	2.34	2.32	3.30	2.19
EPS Growth	-73.51%	-79.94%	0.86%	-29.70%	50.69%	93.81%
Free Cash Flow	1,073	740.45	836.68	908.9	1,055	842.18
Free Cash Flow Per Share	1.25	0.86	0.97	1.05	1.21	1.05
Dividend Per Share	0.300	0.300	0.568	0.550	0.500	0.300
Dividend Growth	-47.18%	-47.18%	3.27%	10.00%	66.67%	7.91%
Gross Margin	29.09%	33.99%	38.53%	39.64%	43.55%	47.44%
Operating Margin	10.12%	15.29%	22.89%	24.88%	25.77%	27.52%
Profit Margin	4.55%	6.14%	27.42%	28.32%	55.13%	54.81%
Free Cash Flow Margin	16.52%	11.21%	11.33%	12.83%	20.24%	26.38%
EBITDA	866.01	1,215	1,876	1,921	1,458	958.59
EBITDA Margin	13.33%	18.40%	25.40%	27.12%	27.97%	30.03%
D&A For EBITDA	208.56	205.22	185.06	158.69	114.71	79.92
EBIT	657.45	1,009	1,690	1,763	1,344	878.67
EBIT Margin	10.12%	15.29%	22.89%	24.88%	25.77%	27.52%
Effective Tax Rate	39.32%	32.60%	13.61%	12.13%	7.95%	8.55%
Revenue as Reported	6,495	6,603	7,384	7,085	5,214	3,192
Advertising Expenses	-	14.1	19.97	19.24	14.45	10.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.